Kindred Biosciences

+$0.01 (+0.11%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KIN and other ETFs, options, and stocks.

About KIN

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M.

CEO
Richard H. Chin
Employees
63
Headquarters
Burlingame, California
Founded
2012

KIN Key Statistics

Market Cap
419.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.11M
High Today
$9.23
Low Today
$9.21
Open Price
$9.22
Volume
1.10M
52 Week High
$9.28
52 Week Low
$3.42

KIN Earnings

-$0.45
-$0.10
$0.25
$0.60
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure